Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool
- Conditions
- Alcohol Use DisorderAddictionAlcohol WithdrawalMotivational InterviewsRelapse
- Registration Number
- NCT06618755
- Lead Sponsor
- University Hospital, Montpellier
- Brief Summary
The aim of this clinical study is to evaluate the efficacy of reinforced inpatient aftercare versus usual care on the percentage of days of abstinence during the first year following withdrawal in adults with alcohol use disorders undergoing inpatient withdrawal. The hypothesis is that reinforced post-withdrawal follow-up, of the motivational interview type, during the first 4 months following hospitalisation, in addition to the usual care, would allow :
* Increase the percentage of days of abstinence in the year following withdrawal.
* Reduce the rate of relapse in the year following withdrawal.
* An increase in the cumulative and maximum duration of abstinence, an increase in motivation to maintain the change initiated and a reduction in the use of other substances in the year following withdrawal.
* A reduction in the impact of risk factors involved in the relapse process in the year following withdrawal.
All participants will have assessments to monitor their abstinence and consumption. In addition to their assessments, the experimental group will have motivational talks once every 15 days.
- Detailed Description
In Europe, and particularly in France, there is a high level of alcohol consumption per capita (2.51 standard drinks/day/inhabitant in France in 2019). This consumption is not without risk, since 7% of all deaths in France in 2015 were attributable to alcohol, not to mention disabling pathologies and injuries. The treatment of alcohol addiction has many facets (social, neurological, psychological, behavioural, etc.) and involves a number of stages. One aspect that is particularly decisive in the consolidation phase of withdrawal (the phase following withdrawal when the risk of relapse is high) is the motivational dimension, which is widely described in the literature. Motivational Interviewing (MI) is a particularly effective tool for initiating and maintaining change. This tool, provided on a regular basis after discharge from hospital, helps to reinforce and maintain abstinence, a change initiated by users at the time of withdrawal.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 104
- With alcohol use disorders defined by at least 2 DSM-V criteria for at least 12 months).
- Being treated for withdrawal in hospital.
- With a goal of complete abstinence.
- With a means of communication (telephone).
- Lack of understanding (written and spoken) of the French language.
- Breach of HC withdrawal contract, following failure to comply with the rules of the addictology service and somatic complications of addiction.
- Eviction from the department, discharge against medical advice during hospitalisation for withdrawal.
- Proven cognitive problems compromising understanding of the implications of the study and the proposed follow-up. proposed follow-up.
- Serious decompensated somatic pathology.
- Non-membership or non-beneficiaries of a national health insurance scheme.
- Person protected by law, under guardianship or curatorship.
- Not having signed free and informed consent to participate in the research.
- Simultaneous participation in another clinical trial.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Percentage of days of abstinence over the 12 months following hospitalization for alcohol From inclusion,once a month for 1 year The measures used for our main criterion will be declarative and collected on paper and by telephone every month in terms of the number of drinks per day. To facilitate data collection, the Timeline Follow Back method \[30\], developed by Sobell and also validated by telephone, will be used. This tool enables estimates of daily consumption of standard glasses to be collected retrospectively (for up to 12 months). The advantage of this method is that it reduces recall bias, since the participant can fill in a calendar from day to day and the data are collected every month.
- Secondary Outcome Measures
Name Time Method Relapse rates at 5 and 12 months From inclusion,once a month for 1 year Percentage of patients who have relapsed (above WHO recommendations for low-risk drinking) at least once in the 5 and 12 months following hospitalisation for alcohol withdrawal. This relapse rate will be calculated on the basis of the consumption schedule collected using the method presented for the primary endpoint.
As a reminder, the recommendations for lower-risk drinking are as follows:
* No more than 10 standard drinks per week
* No more than 2 standard drinks per day
* Have days of the week when no alcohol is consumed.Cumulative duration (in days) and maximum duration of abstinence over 5 and 12 months Assessed 5 months after inclusion and 12 months after inclusion These cumulative and maximum periods of abstinence will be based on the consumption calendar collected using the Timeline Follow Back method.
Motivation to maintain abstinence Assessed 0 month, 5 months and 12 months after inclusion Assessed using the Stages of Change Readiness and Treatment Eagerness Scale questionnaire
Craving felt Assessed 0 month, 5 months and 12 months after inclusion Assessed using the Obsessive Compulsive Drinking Scale
Effectiveness of coping strategies Assessed 0 month, 5 months and 12 months after inclusion Assessed using the Way og Coping Checklist questionnaire
Level of anxiety/depression Assessed 0 month, 5 months and 12 months after inclusion Assessed using the Hospital Anxiety and Depression scale questionnaire
Sense of personal effectiveness Assessed 0 month, 5 months and 12 months after inclusion Assessed using the Sherer General Self-Efficacy Scale
Use of other substances Assessed 0 month, 5 months and 12 months after inclusion Collection of data declarative data on consumption and quantification in the previous month
Trial Locations
- Locations (1)
Thomas RISDORFER DE ISSDENTZI
🇫🇷Montpellier, France